glp-1 medications and surgery New Year, New Bod? Words of advice for Plastic patients on Ozempic Are GLP-1 medications helping—or complicating—surgical

Antioxidant Functions BPC-157 has been demonstrated to reduce nitric oxide and malondialdehyde (MDA) levels in rat studies

injected once daily Adlyxin (lixisenatide) Short-acting

In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions

Mikki evaluates your health status, hormone levels, and goals to determine if CJC-1295/Ipamorelin aligns with your wellness objectives

They offer a more effective, lasting impact on your weight by physically altering your stomach

No lab work required to start treatment